HIV and AIDS Trial, Recruiting NCT06145828 Sponsor: Guangzhou 8th People's Hospital Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT06145828
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a confirmed HIV infection
  • People whose HIV has progressed to AIDS, meaning their CD4+ immune cell count is below 200 cells/ul and/or they have developed an AIDS-related opportunistic infection
  • People between 18 and 65 years of age
  • People who have been diagnosed with either severe pneumonia (based on 2021 American Thoracic Society and Infectious Diseases Society of America guidelines) or septic shock, a serious condition where infection causes dangerous drops in blood pressure (based on Chinese critical care guidelines)

Who may not be able to join:

  • People who have lesions or abnormalities affecting the brain or central nervous system, serious liver disease, or scarring of the liver (cirrhosis)
  • People who have any tumour or cancer, whether related to AIDS or not
  • People who are pregnant or currently breastfeeding
  • People who have serious pre-existing conditions affecting the heart, lungs, liver, or kidneys
  • People with a history of alcohol abuse or drug use
  • People whose overall health condition, in the trial doctor's judgement, would affect the ability to properly complete or evaluate the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Linghua Li, PhD, Guangzhou Eighth People's Hospital

Phone: +862083710825

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Guangzhou 8th People's Hospital
Registry
ClinicalTrials.gov
Start date
23 October 2023
Est. completion
23 October 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Mortality rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov